384 related articles for article (PubMed ID: 9250666)
1. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
Lavau C; Szilvassy SJ; Slany R; Cleary ML
EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
Slany RK; Lavau C; Cleary ML
Mol Cell Biol; 1998 Jan; 18(1):122-9. PubMed ID: 9418860
[TBL] [Abstract][Full Text] [Related]
3. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells.
Rubnitz JE; Morrissey J; Savage PA; Cleary ML
Blood; 1994 Sep; 84(6):1747-52. PubMed ID: 8080983
[TBL] [Abstract][Full Text] [Related]
4. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations.
Morrissey JJ; Raney S; Cleary ML
Leuk Res; 1997 Oct; 21(10):911-7. PubMed ID: 9403001
[TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
Lavau C; Luo RT; Du C; Thirman MJ
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10984-9. PubMed ID: 10995463
[TBL] [Abstract][Full Text] [Related]
6. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract][Full Text] [Related]
7. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
[TBL] [Abstract][Full Text] [Related]
8. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.
DiMartino JF; Ayton PM; Chen EH; Naftzger CC; Young BD; Cleary ML
Blood; 2002 May; 99(10):3780-5. PubMed ID: 11986236
[TBL] [Abstract][Full Text] [Related]
9. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.
García-Cuéllar MP; Schreiner SA; Birke M; Hamacher M; Fey GH; Slany RK
Oncogene; 2000 Mar; 19(14):1744-51. PubMed ID: 10777208
[TBL] [Abstract][Full Text] [Related]
10. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator.
Schreiner SA; García-Cuéllar MP; Fey GH; Slany RK
Leukemia; 1999 Oct; 13(10):1525-33. PubMed ID: 10516753
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias.
Rubnitz JE; Behm FG; Curcio-Brint AM; Pinheiro RP; Carroll AJ; Raimondi SC; Shurtleff SA; Downing JR
Blood; 1996 Jun; 87(11):4804-8. PubMed ID: 8639852
[TBL] [Abstract][Full Text] [Related]
12. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner.
Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG
Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173
[TBL] [Abstract][Full Text] [Related]
13. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
[TBL] [Abstract][Full Text] [Related]
14. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins.
Adler HT; Chinery R; Wu DY; Kussick SJ; Payne JM; Fornace AJ; Tkachuk DC
Mol Cell Biol; 1999 Oct; 19(10):7050-60. PubMed ID: 10490642
[TBL] [Abstract][Full Text] [Related]
15. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL.
Bernard OA; Mauchauffe M; Mecucci C; Van den Berghe H; Berger R
Oncogene; 1994 Apr; 9(4):1039-45. PubMed ID: 8134107
[TBL] [Abstract][Full Text] [Related]
16. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias.
Morrissey J; Tkachuk DC; Milatovich A; Francke U; Link M; Cleary ML
Blood; 1993 Mar; 81(5):1124-31. PubMed ID: 8443374
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of the MEN, MLL/MEN and truncated MLL proteins expressed in leukemic cells carrying the t(11;19)(q23;p13.1) translocation.
Kanda Y; Mitani K; Tanaka T; Tanaka K; Ogawa S; Yazaki Y; Hirai H
Int J Hematol; 1997 Aug; 66(2):189-95. PubMed ID: 9277049
[TBL] [Abstract][Full Text] [Related]
18. Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells.
Horton SJ; Grier DG; McGonigle GJ; Thompson A; Morrow M; De Silva I; Moulding DA; Kioussis D; Lappin TR; Brady HJ; Williams O
Cancer Res; 2005 Oct; 65(20):9245-52. PubMed ID: 16230385
[TBL] [Abstract][Full Text] [Related]
19. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
[TBL] [Abstract][Full Text] [Related]
20. Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications.
Waring PM; Cleary ML
Curr Top Microbiol Immunol; 1997; 220():1-23. PubMed ID: 9103672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
